EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

New therapeutic strategies for higher cure rates: high dose therapy and new therapeutic modalities. Proceedings of the 12th Bristol-Myers Squibb Nagoya International Cancer Treatment Symposium. Nagoya, Japan, 4-5 October 1996


Cancer ChemoTherapy and Pharmacology 40 Suppl: S1-118
New therapeutic strategies for higher cure rates: high dose therapy and new therapeutic modalities. Proceedings of the 12th Bristol-Myers Squibb Nagoya International Cancer Treatment Symposium. Nagoya, Japan, 4-5 October 1996


Accession: 046800728

PMID: 9289398



Related references

New concepts of treatment strategies for hormone-related cancer. Proceedings of the 20th Bristol-Myers Squibb Nagoya International Cancer Treatment Symposium. March 11-12, 2005. Nagoya, Japan. Cancer ChemoTherapy and Pharmacology 56 Suppl 1: 1-99, 2005

State of the art for digestive organs. Proceedings of the 19th Bristol-Myers Squibb Nagoya International Cancer Treatment Symposium. November 14-15, 2003. Nagoya, Japan. Cancer ChemoTherapy and Pharmacology 54 Suppl 1: S1-90, 2004

Challenges in Cancer Metastasis. Proceedings of the 14th Bristol-Myers Squibb Nagoya International Cancer Treatment Symposium. Nagoya, Japan, 11-12 September 1998. Cancer ChemoTherapy and Pharmacology 43 Suppl: S1-103, 1999

The 21st Bristol-Myers Squibb Nagoya International Cancer Treatment Symposium, Lung Cancer: Novel Therapy Against Malfunctioning Molecules - 24-25 February 2006 - Nagoya, Japan - Preface. Cancer Chemotherapy and Pharmacology 58(Suppl. 1): S1-S3, 2006

The 11th Bristol-Myers Squibb Nagoya International Cancer Treatment Symposium. Cytokines and New Anticancer Agents on the Horizon of Oncology. Nagoya, Japan, 24-25 November 1995. Cancer ChemoTherapy and Pharmacology 38 Suppl: S1-119, 1996

The 20th Bristol-Myers Squibb Nagoya International Cancer Treatment Symposium, New Concepts of Treatment Strategies for Hormone-Related Cancer - Preface. Cancer Chemotherapy and Pharmacology 56(Suppl. 1): S1-S3, 2005

International Congress Series, No 1048 Cancer chemotherapy Challenges for the future, Vol 8; 8th Nagoya International Symposium on Cancer Treatment, Nagoya, Japan, October 16-17, 1992. Kimura, K , Yamada, K , Carter, S K , Longo, D L International Congress Series; Cancer chemotherapy: Challenges for the future, Vol 8 xii+324p, 1993

International Congress Series, No 1078 Cancer chemotherapy Challenges for the future, Vol 9; Ninth Nagoya International Symposium on Cancer Treatment, Nagoya, Japan, September 17-18, 1993. Kimura, K , Ota, K , Carter, S K , Friedmann, T International Congress Series; Cancer chemotherapy: Challenges for the future, Vol 9 ix+240p, 1994

Bristol myers squibb cancer symposia vol 12 molecular mechanisms and their clinical application in malignancies twelfth annual bristol myers squibb symposium on cancer research toronto ontario canada september 26 27 1989. Bergsagel, D E And T W Mak Bristol-Myers Squibb Cancer Symposia, Vol 12 Molecular Mechanisms And Their Clinical Application in Malignancies; Twelfth Annual Bristol-Myers Squibb Symposium on Cancer Research, Toronto, Ontario, Canada, September 26-27, 1989 Xxii+270p Academic Press, Inc : San Diego, California, Usa; London, England, Uk Illus Xxii+270p, 1991

Endotoxin and sepsis: molecular mechanisms of pathogenesis, host resistance, and therapy. Proceedings of the 4th Conference of the International Endotoxin Society. Nagoya, Japan, October 23-27, 1996. Progress in Clinical and Biological Research 397: 1-398, 1998